Nicotine reduces the cytotoxic effect of glycated proteins on microglial cells

Neurochemical Research

Volumn 35, Issue 4, 2010, Pages 548-558

  Khazaei, Mohammad R ^a,b   Bakhti, Mostafa ^a   Habibi Rezaei, Mehran ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Alzheimer's disease; Glycation; Microglial cells; Nicotine; Secondary structure

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BOVINE SERUM ALBUMIN; CONGO RED; GLUCOSE; GLYCOSYLATED PROTEIN; LIPOCORTIN 5; NICOTINE; NITRIC OXIDE; PROPIDIUM IODIDE; REACTIVE OXYGEN METABOLITE; THIOFLAVINE;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; BETA SHEET; CELL ACTIVATION; CELL ISOLATION; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; DENATURATION; MICROGLIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN GLYCOSYLATION; PROTEIN SECONDARY STRUCTURE; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; CIRCULAR DICHROISM; GLUCOSE; MICROGLIA; NERVE TISSUE PROTEINS; NICOTINE; PROTEIN STRUCTURE, SECONDARY; RATS; RATS, WISTAR; RECEPTORS, IMMUNOLOGIC;

BOVINAE;

EID: 77953539682     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0095-5     Document Type: Article

References (50)

1. Yan SF, Ramasamy R, Schmidt AM (2008) Mechanisms of disease: advanced glycation end products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 4:285-293
2. Takeuchi M, Yamagishi S (2008) Possible involvement of advanced glycation end-products, AGEs, in the pathogenesis of Alzheimer's disease. Curr Pharm Des 14:973-978
3. Sugimoto K, Yasujima M, Yagihashi S (2008) Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des 14:953-961
4. Valencia JV, Weldon SC, Quinn D et al (2004) Advanced glycation end product ligands for the receptor for advanced glycation endproducts: biochemical characterization and formation kinetics. Anal Biochem 324:68-78
5. Grossman H (2003) Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease. CNS Spectr 8:815-823
6. Bouma B, Kroon-Batenburg LMJ, Wu YP et al (2003) Glycation induces formation of amyloid cross-b structure in albumin. J Biol Chem 278:41810-41819
7. Chiti F, Webster P, Taddei N et al (1999) Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci USA 96:3590-3594
8. Obrenovich ME, Monnier VM (2004) Glycation stimulates amyloid formation. Sci Aging Knowledge Environ 2004:pe3
9. Khazaei MR, Habibi-Rezaei M, Karimzadeh F et al (2008) Microglial cell death induced by glycated bovine serum albumin: nitric oxide involvement. J Biochem 144:197-206
10. Gharibyan AL, Zamotin V, Yanamandra K et al (2007) Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways. J Mol Biol 365:1337-1349
11. Yan SD, Chen X, Fu J et al (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382:685-691
12. Yan SD, Zhu H, Fu J et al (1997) Amyloid beta-peptide receptor for advanced glycation end product interaction elicits neuronal expression of macrophage colony stimulating factor: a proinflammatory pathway in Alzheimer's disease. Proc Natl Acad Sci USA 94:5296-5301
13. Dasgupta S, Jana M, Liu X et al (2002) Myelin basic proteinprimed T cells induce nitric oxide synthase in microglial cells: implications for multiple sclerosis. J Biol Chem 277:39327-39333
14. Yan SD, Chen X, Scmidt AM et al (1994) Glycated tau protein in Alzheimer's disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 91:7781-7791
15. Vitek MP, Bhattacharya K, Glendening JM et al (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91:4766-4770
16. Ono K, Hasegawa K, Yamada M et al (2002) Nicotine breaks down preformed Alzheimer's beta-amyloid fibrils in vitro. Biol Psychiatry 52:880-886
17. Yang F, Lim GP, Begum AN et al (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892-5901
18. Necula M, Kayed R, Milton S et al (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282:10311-10324
19. Campiglia P, Esposito C, Scrima M et al (2007) Conformational stability of A beta-, 25-35 in the presence of thiazolidine derivatives. Chem Biol Drug Des 69:111-118
20. Moore SA, Huckerby TN, Gibson GL et al (2004) Both the D-,+ and L-,-enantiomers of nicotine inhibit A beta aggregation and cytotoxicity. Biochemistry 43:819-826
21. Salomon AR, Marcinowski KJ, Friedland RP et al (1996) Nicotine inhibits amyloid formation by the β-peptide. Biochemistry 35:13568-13578
22. Habeeb AF (1966) Determination of free amino groups in proteins by trinitrobenzene sulfonic acid. Anal Biochem 14:328-336
23. Giulian D, Baker TJ (1986) Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6:2163-2178
24. Fernandez-Botran R, Vetvicka V (2001) Methods in cellular immunology. CRC Press, Boca Raton
25. Pick E (1986) Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader. Methods Enzymol 132:407-421
26. Klunk WE, Jacob RF, Mason RP (1999) Quantifying amyloid by Congo red spectral shift assay. Methods Enzymol 309:285-305
27. Yeargans GS, Seidler NW (2003) Carnosine promotes the heat denaturation of glycated protein. Biochem Biophys Res Commun 300:75-80
28. Seidler NW, Seibel I (2000) Glycation of a spartate amino transferase and conformational flexibility. Biochem Biophys Res Commun 277:47-50
29. Block ML, Zecca L, Hong J (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8:57-69
30. Wautier MP, Chappey O, Corda S et al (2001) Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280:E685-E694
31. Koopman G, Reutelingsperger CP et al (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415-1420
32. Hellstrom-Lindahl E, Court J, Keverne J et al (2004) Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. Eur J Neurosci 19:2703-2710
33. Zamani MR, Allen YS (2001) Nicotine and its interaction with bamyloid protein: a short review. Biol Psychiatry 49:221-232
34. Roelfes G, Mootz HD (2006) Probing the molecular basis of protein function through chemistry. Chem Biochem 7:545-549
35. Zeng H, Zhang Y, Peng LJ et al (2001) Nicotine and amyloid formation. Biol Psychiatry 49:248-257
36. Lerner A, Koss E, Debanne S et al (1997) Smoking and oestrogen- replacement therapy as protective factors for Alzheimer's disease. Lancet 349:403-404
37. Wilson AL, Langley LK, Monley J et al (1995) Nicotine patches in Alzheimer's disease: pilot study on learning, memory, and safety. Pharmacol Biochem Behav 51:509-514
38. Ulrich J, Johannson-Locher G, Seiler WO et al (1997) Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history. Acta Neuropathol 94:450-454
39. Buckingham SB, Jones AK, Brown LA et al (2009) Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection. Pharmacol Rev 61:39-61
40. Liu Q, Zhao B (2004) Nicotine attenuates beta-amyloid peptideinduced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures. Br J Pharmacol 141:746-754
41. Zhang J, Liu Q, Chen Q et al (2006) Nicotine attenuates betaamyloid-induced neurotoxicity by regulating metal homeostasis. FASEB J 20:1212-1214
42. Wu X, Sun H, Liu Y (2000) The conformation alteration of mouse hepatic histones after reaction with nicotine in vitro. Chin Sci Bull 45:825-829
43. Seidler NW, Yeargans GS (2002) Effects of thermal denaturation on protein glycation. Life Sci 70:1789-1799
44. Carter DC, Ho JX (1994) Structure of serum albumin. Adv Protein Chem 45:153-203
45. Wetzel R, Becker M, Behlke J et al (1980) Temperature behaviour of human serum albumin. Eur J Biochem 104:469-478
46. Lin VJC, Koenig JL (1976) Raman studies of bovine serum albumin. Biopolymers 15:203-218
47. Clark AH, Judge FJ, Richards JB et al (1981) Electron microscopy of network structures in thermally-induced globular protein gels. Int J Pept Protein Res 17:380-392
48. Clark AH, Saunderson DHP, Suggett A (1981) Infrared and laserraman spectroscopic studies of thermally-induced globular protein gels. Int J Pept Protein Res 17:353-364
49. Yousefi R, Ardestani SK, Saboury AA et al (2005) Investigation on the surface hydrophobicity and aggregation kinetics of human calprotectin in the presence of calcium. J Biochem Mol Biol 38:407-413
50. Banati RB, Gehrmann J, Schubert P et al (1993) Cytotoxicity of microglia. Glia 7:111-118